These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12010684)

  • 21. New developments in staging and follow-up of patients with Hodgkin's lymphoma.
    van Spronsen DJ; Veldhuis GJ
    Neth J Med; 2003 Sep; 61(9):278-84. PubMed ID: 14692440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results.
    Rigacci L; Castagnoli A; Dini C; Carpaneto A; Matteini M; Alterini R; Carrai V; Nassi L; Bernardi F; Pieroni C; Bosi A
    Oncol Rep; 2005 Nov; 14(5):1209-14. PubMed ID: 16211287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.
    Even-Sapir E; Lievshitz G; Perry C; Herishanu Y; Lerman H; Metser U
    Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspects].
    Staak JO; Dietlein M; Engert A; Weihrauch MR; Schomäcker K; Fischer T; Eschner W; Borchmann P; Diehl V; Schicha H; Schnell R
    Nuklearmedizin; 2003 Feb; 42(1):19-24. PubMed ID: 12601450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
    Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
    Haematologica; 2001 Mar; 86(3):266-73. PubMed ID: 11255273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. False-positive FDG-PET imaging of the thymus of a child with Hodgkin's disease.
    Weinblatt ME; Zanzi I; Belakhlef A; Babchyck B; Kochen J
    J Nucl Med; 1997 Jun; 38(6):888-90. PubMed ID: 9189136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hodgkin's and non-Hodgkin's lymphomas.
    Rademaker J
    Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic evaluation and prognostic value of interim hybrid PET/CT with (18)F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma.
    Zhao J; Qiao W; Wang C; Wang T; Xing Y
    Hematology; 2007 Oct; 12(5):423-30. PubMed ID: 17852456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDG-PET response-adapted therapy: is 18F-fluorodeoxyglucose positron emission tomography a safe predictor for a change of therapy?
    Hutchings M
    Hematol Oncol Clin North Am; 2014 Feb; 28(1):87-103. PubMed ID: 24287070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
    Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence?
    Juweid ME
    J Nucl Med; 2008 Jan; 49(1):9-12. PubMed ID: 18077522
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods].
    Pichler R; Maschek W; Hatzl-Griesenhofer M; Huber H; Wimmer G; Wahl G; Fridrik M
    Nuklearmedizin; 2000 Sep; 39(6):166-73. PubMed ID: 11057408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonossifying fibroma can mimic residual lymphoma in FDG PET: additional value of combined PET/CT.
    von Falck C; Rosenthal H; Gratz KF; Galanski M
    Clin Nucl Med; 2007 Aug; 32(8):640-2. PubMed ID: 17667441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas.
    Kumar R; Maillard I; Schuster SJ; Alavi A
    Radiol Clin North Am; 2004 Nov; 42(6):1083-100. PubMed ID: 15488559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.
    Hoh CK; Glaspy J; Rosen P; Dahlbom M; Lee SJ; Kunkel L; Hawkin RA; Maddahi J; Phelps ME
    J Nucl Med; 1997 Mar; 38(3):343-8. PubMed ID: 9074514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY; Kao A; Yen RF
    Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's disease.
    Ansquer C; Hervouët T; Devillers A; de Guibert S; Gastinne T; Le Gouill S; Garin E; Moreau A; Kraeber-Bodéré F; Lamy T
    Haematologica; 2008 Jan; 93(1):128-31. PubMed ID: 18166797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte colony-stimulating factor: confounding F-18 FDG uptake in outpatient positron emission tomographic facilities for patients receiving ongoing treatment of lymphoma.
    Gundlapalli S; Ojha B; Mountz JM
    Clin Nucl Med; 2002 Feb; 27(2):140-1. PubMed ID: 11786751
    [No Abstract]   [Full Text] [Related]  

  • 39. A strange case of phyllodes tumor detected using (18)F-FDG PET/CT in an adolescent patient affected by Hodgkin lymphoma: a possible pitfall.
    Cucinotta M; Quartuccio N; Coppolino P; La Delfa V; Bianchi M; Fagioli F; Cistaro A
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):e201-5. PubMed ID: 25240649
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
    Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
    Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.